Cargando…

Human Serum Proteins and Susceptibility of Acinetobacter baumannii to Cefiderocol: Role of Iron Transport

Cefiderocol, a recently introduced antibiotic, has a chemical structure that includes a cephalosporin that targets cell wall synthesis and a chlorocatechol siderophore moiety that facilitates cell penetration by active iron transporters. Analysis of the effect that human serum, human serum albumin,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le, Casin, Pimentel, Camila, Pasteran, Fernando, Tuttobene, Marisel R., Subils, Tomás, Escalante, Jenny, Nishimura, Brent, Arriaga, Susana, Carranza, Aimee, Mezcord, Vyanka, Vila, Alejandro J., Corso, Alejandra, Actis, Luis A., Tolmasky, Marcelo E., Bonomo, Robert A., Ramírez, Maria Soledad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945497/ https://www.ncbi.nlm.nih.gov/pubmed/35327400 http://dx.doi.org/10.3390/biomedicines10030600

Ejemplares similares

Acinetobacter baumannii response to cefiderocol challenge in human urine
por: Nishimura, Brent, et al.
Publicado: (2022)

The Iron Content of Human Serum Albumin Modulates the Susceptibility of Acinetobacter baumannii to Cefiderocol
por: Escalante, Jenny, et al.
Publicado: (2023)

Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
por: Mezcord, Vyanka, et al.
Publicado: (2023)

Involvement of the Histone-Like Nucleoid Structuring Protein (H-NS) in Acinetobacter baumannii’s Natural Transformation
por: Le, Casin, et al.
Publicado: (2021)

Interaction of Acinetobacter baumannii with Human Serum Albumin: Does the Host Determine the Outcome?
por: Pimentel, Camila, et al.
Publicado: (2021)

Effect of serum albumin, a component of human pleural fluid, on transcriptional and phenotypic changes on Acinetobacter baumannii A118
por: Le, Casin, et al.
Publicado: (2021)

Histone-like nucleoid-structuring protein (H-NS) regulatory role in antibiotic resistance in Acinetobacter baumannii
por: Rodgers, Deja, et al.
Publicado: (2021)

Human serum albumin (HSA) regulates the expression of histone-like nucleoid structure protein (H-NS) in Acinetobacter baumannii
por: Escalante, Jenny, et al.
Publicado: (2022)

Human Pleural Fluid and Human Serum Albumin Modulate the Behavior of a Hypervirulent and Multidrug-Resistant (MDR) Acinetobacter baumannii Representative Strain
por: Pimentel, Camila, et al.
Publicado: (2021)

Genomic Comparative Analysis of Two Multi-Drug Resistance (MDR) Acinetobacter baumannii Clinical Strains Assigned to International Clonal Lineage II Recovered Pre- and Post-COVID-19 Pandemic
por: Traglia, German Matias, et al.
Publicado: (2023)

Staphylococcus aureus α-Toxin Effect on Acinetobacter baumannii Behavior
por: Fernandez, Jennifer S., et al.
Publicado: (2022)

Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii
por: Martinez, Jasmine, et al.
Publicado: (2021)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) Isolates
por: Pasteran, Fernando, et al.
Publicado: (2021)

Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
por: Cedano, Jose, et al.
Publicado: (2022)

Antimicrobial activity of the Lacticaseibacillus rhamnosus CRL 2244 and its impact on the phenotypic and transcriptional responses in carbapenem resistant Acinetobacter baumannii
por: Rodriguez, Cecilia, et al.
Publicado: (2023)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Phenotypic and transcriptional analysis of the antimicrobial effect of lactic acid bacteria on carbapenem-resistant Acinetobacter baumannii: Lacticaseibacillus rhamnosus CRL 2244 an alternative strategy to overcome resistance?”
por: Rodriguez, Cecilia, et al.
Publicado: (2023)

Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
por: Ramirez, Maria Soledad, et al.
Publicado: (2020)

Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress
por: Martinez, Jasmine, et al.
Publicado: (2019)

BlsA integrates light and temperature signals into iron metabolism through Fur in the human pathogen Acinetobacter baumannii
por: Tuttobene, Marisel R., et al.
Publicado: (2018)

Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii
por: Raro, Otávio Hallal Ferreira, et al.
Publicado: (2023)

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol
por: Dagher, Michael, et al.
Publicado: (2020)

The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in Acinetobacter baumannii
por: Huang, Fanny, et al.
Publicado: (2020)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates
por: Ballesté-Delpierre, Clara, et al.
Publicado: (2022)

Identification of Potential Virulence Factors in the Model Strain Acinetobacter baumannii A118
por: Ramirez, Maria S., et al.
Publicado: (2019)

Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection
por: Mabayoje, Diana A, et al.
Publicado: (2021)

Blue light directly modulates the quorum network in the human pathogen Acinetobacter baumannii
por: Tuttobene, Marisel Romina, et al.
Publicado: (2021)

An Acinetobacter non-baumannii Population Study: Antimicrobial Resistance Genes (ARGs)
por: Baraka, Adam, et al.
Publicado: (2020)

2759. Cefiderocol vs Best Available Therapy for the Treatment of Carbapenem- Resistant Acinetobacter baumannii
por: Daisey, Gabrielle N, et al.
Publicado: (2023)

Draft Genome of the Multidrug-Resistant Acinetobacter baumannii Strain A155 Clinical Isolate
por: Arivett, Brock A., et al.
Publicado: (2015)

2134. Impact of ADC ß-lactamase amino acid variation on cefiderocol (FDC) susceptibility in carbapenem-resistant Acinetobacter baumannii (CRAb) strains
por: Iovleva, Alina, et al.
Publicado: (2023)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates
por: Seifert, Harald, et al.
Publicado: (2023)

Whole-Genome Sequence Analysis of the Naturally Competent Acinetobacter baumannii Clinical Isolate A118
por: Traglia, German M., et al.
Publicado: (2014)

Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in Acinetobacter baumannii
por: Liu, Xiaochen, et al.
Publicado: (2023)

Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
por: Iregui, Alejandro, et al.
Publicado: (2020)

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples
por: Carcione, Davide, et al.
Publicado: (2021)

666. Outcomes Using Cefiderocol for the Treatment of Acinetobacter baumannii Infections from the PROVE (Real-World Evidence) Study
por: Marcella, Stephen, et al.
Publicado: (2022)

In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience
por: Quirino, Angela, et al.
Publicado: (2023)

Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Acinetobacter baumannii
por: Kolesnik-Goldmann, Natalia, et al.
Publicado: (2023)

Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia
por: Delgado-Valverde, Mercedes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3bp9blp02e0euqijevqjle831p